comparison of i-gelTM and ambu AuraGain as a conduit for blind endotracheal intubation in adult patients in elective surgeries.
试验速览
- 阶段
- Phase 3 4
- 状态
- 尚未招募
- 发起方
- 入组人数
- 130
- 试验地点
- 1
- 主要终点
- To compare success rate of blind endotracheal intubation through i-gelTM & Ambu AuraGain.
研究概览
简要总结
The Ambu AuraGain laryngeal mask airway (Ambu A/S, Ballerup Denmark) is a newer secondgeneration supraglottic airway device launched in June 2014. It is a single use SAD made of polyvinylchloride (PVC) and is anatomically curved to follow the human airway and promises to provide high seal pressures [Figure 1]. In addition, it has an integrated gastric access, a bite block, and a wider airway tube and can be used as conduit for direct blind intubation and fiberoptic guided intubation. The purpose of this study is to compare the blind endotracheal intubation 2 through i-gelTM and Ambu AuraGain in adults in elective surgery.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Investigator Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)(—)
- 性别
- All
入选标准
- •BELONGING TO ASA PHYSICAL STATUS I OR II.
排除标准
- •Patients with pregnancy, known or predicted difficult airway, reduced lung compliance, inter incisor gap < 3.0cm, BMI >35 kg/m2 , High risk for pulmonary aspiration (non fasted, gastroesophageal reflux disease).
结局指标
主要结局
To compare success rate of blind endotracheal intubation through i-gelTM & Ambu AuraGain.
时间窗: 48weeks
次要结局
- 1. To compare success rate of device [SAD] insertion [Number of insertion attempts, time of(insertion].)
